| Course | DNRS 6521 Advanced Pharmacology (DNP level) |
|---|---|
| Week | Week 5 |
| Paper type | Discussion post with two peer replies |
| Length | About 550 words, 3 pages |
| Format | Discussion post, APA 7 citations |
| School | Walden University |
| Program | Doctor of Nursing Practice (DNP) |
| Updated | October 2026 |
Free sample paper for DNRS 6521 Week 5
Week 5 Discussion: Initial Post
Three Changes in an Older Body and What Each One Does to a Drug
Body composition shifts predictably with age, and it changes distribution for whole categories of drugs. Between early adulthood and old age, fat makes up a growing share of body mass while the share that is water shrinks, even when weight is stable. A lipid-soluble drug therefore has a larger volume in which to distribute. Diazepam is the classic example: in a study of healthy adults across a range of ages, its half-life lengthened steadily with age, mainly because its volume of distribution grew while its clearance changed little (Klotz et al., 1975). The consequence is that the drug accumulates slowly over days to weeks of regular use and lingers after it is stopped, so an older adult may seem fine in the first week and become drowsy or unsteady in the third. A water-soluble drug does the opposite: with less body water, the same dose produces a higher concentration, so drugs such as lithium or digoxin reach higher levels from a standard dose (Mangoni & Jackson, 2004).
Reduced elimination capacity is gradual, not a threshold, and that is harder to write about than it sounds. Kidney function declines on average across adult life, but the decline varies widely between people, and there is no age at which a patient crosses from normal to impaired. Serum creatinine can stay within the laboratory's normal range while clearance falls, because older adults usually have less muscle mass and produce less creatinine. The consequence is that doses of renally cleared drugs need to follow an estimate of the patient's actual kidney function, rechecked over time, rather than age alone, and a normal creatinine in an 85-year-old should not be read as normal kidney function (Mangoni & Jackson, 2004).
Altered receptor response is the least well characterized of the three, and I want to mark it as such. Some effects are well documented: older adults are more sensitive to the central nervous system effects of benzodiazepines at the same concentration, which is one reason the Beers Criteria list them among drugs older adults should generally not be given (American Geriatrics Society Beers Criteria Update Expert Panel, 2023). Other effects run the other way, with a blunted response to beta-adrenergic drugs. But for many drug classes the evidence is thinner, and it is hard to separate a true change in receptor sensitivity from the pharmacokinetic changes above. The consequence is caution with sedatives and anticholinergics even when levels are expected to be ordinary.
Which of the three do you think is most often overlooked in practice, and what evidence would you point to?
Reply to Rachel
Rachel, you chose reduced hepatic metabolism as the most important change. I would push on the evidence: for many drugs, the fall in liver blood flow and mass with age is well described, but the effect on specific enzymes varies. Which drug would you use to show that metabolism, rather than distribution, explains the change in your patient?
Reply to Kevin
Kevin, your point about falling albumin is interesting, but in healthy older adults albumin usually declines only slightly; large falls tend to come with illness or malnutrition. Would you attribute your patient's higher free phenytoin to age, or to her acute illness?
References
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71(7), 2052-2081. https://doi.org/10.1111/jgs.18372
Klotz, U., Avant, G. R., Hoyumpa, A., Schenker, S., & Wilkinson, G. R. (1975). The effects of age and liver disease on the disposition and elimination of diazepam in adult man. The Journal of Clinical Investigation, 55(2), 347-359. https://doi.org/10.1172/JCI107938
Mangoni, A. A., & Jackson, S. H. D. (2004). Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. British Journal of Clinical Pharmacology, 57(1), 6-14. https://doi.org/10.1046/j.1365-2125.2003.02007.x
DNRS 6521 Week 5 instructions, in plain terms
A mid-term thread commonly asks how normal aging changes pharmacokinetics or pharmacodynamics and what that means for prescribing to older adults. You choose a small number of age-related changes, explain the mechanism and give the consequence for drug handling or response, ideally with an example class. Have the first post up by Wednesday or so, with the textbook and one study or guideline cited in APA 7. Then answer two classmates, giving each reply a citation of its own. Some sections ask you to tie the discussion to the Beers Criteria or another tool for potentially inappropriate medications. Keep the post analytical: each change should end with a consequence clause that says what happens to the drug. A few hundred words is typical for the initial post.
How this DNRS 6521 Week 5 example is built
Three paragraphs, each built on one physiologic change and its consequence, with no paragraph permitted to name a change without following it through. Body composition opens, since the shift in the proportions of water and fat tissue changes distribution for whole categories of agents and does so predictably. Reduced elimination capacity follows, stated as a gradual change rather than as a threshold, which is the accurate version and also the harder one to write. Altered receptor response closes the set, and the post is careful to mark it as the least well characterized of the three. Three current sources sit inline. The final question asks which of the three changes is most often overlooked, which invites disagreement backed by evidence.
DNRS 6521 Week 5 rubric: what earns full marks
Threads on aging attract description, so the analysis share is unusually easy to identify and unusually often missed. Credit follows the consequence clause in each paragraph, the part saying what a physiologic change does to handling, and a post listing three changes without those clauses scores as accurate and shallow. Graders watch for threshold language, since describing elimination as failing at an age contradicts the evidence the same post cites. Marking the least characterized claim generally gains credit rather than losing it. Sections also read replies more severely by the midpoint of a term, and a response that praises a peer's organization before adding a personal observation earns participation and nothing else. Currency of sources is checked here as elsewhere in the sequence.
Common DNRS 6521 Week 5 mistakes, and how to avoid them
Posts on aging lose credit when they describe the changes accurately but never say what they do to a medication. Close every point with a consequence. Another mistake is covering ten changes thinly; three developed well score better. Students often state that older adults "metabolize drugs more slowly" as a blanket rule, but phase I and phase II pathways age differently, so be specific. Avoid naming agents you cannot connect to the change you describe. Serum creatinine can look normal in an older adult with low muscle mass, which matters if you discuss kidney clearance. In replies, test one claim with evidence rather than agreeing. Check that the Beers Criteria year in your citation matches the reference.
Get a DNRS 6521 Week 5 example written to your instructions
Send the prompt, the population the classroom specified and the reply count the section enforces, and a post organized by physiologic change rather than by product comes back to you. The first custom one is free and returns inside 24 to 48 hours. Nobody on your own caseload needs describing for this, and none is described.
More DNRS 6521 papers and DNP samples
- DNRS 6521 Week 1: Discussion Post
- DNRS 6521 Week 2: Case Write-Up
- DNRS 6521 Week 3: Pharmacogenomic Memo
- DNRS 6521 Week 4: Decision Case
- DNRS 6521 Week 6: Interaction Analysis
- DNRS 6521 Week 7: Monitoring Plan
- DNRS 6521 Week 8: Prescribing Ethics Case
- DNRS 6521 Week 9: Formulary Review
- DNRS 6521 Week 10: Deprescribing Plan
- DNRS 6521 Week 11: QI Proposal
- NURS 6001 Week 5: Research article pair analysis
- DNRS 6501 Week 5: Discussion Post
- NURS 6002 Week 5: Nursing association membership case
- NURS 6914 Week 5: Ethics case analysis
DNRS 6521 Week 5 questions, answered
Does this course cover pediatric handling as well?
Many doctoral pharmacology sequences treat both ends of the lifespan, sometimes in the same week and sometimes across two. Walden does not publish which. The example takes older adults because that is the more common single-week assignment, and the same one-change-per-paragraph structure applies unchanged if your prompt asks about children instead.
Should the post name agents that need caution?
Lists of that kind answer a different question and tend to collect knowledge credit only. The example stays on physiology and lets the consequences generalize. If your prompt explicitly asks for examples, the strongest form attaches each one to the physiologic change that makes it relevant rather than presenting a list on its own.
How many changes should one post cover?
Three, followed through properly, outscore six named in passing in nearly every rubric of this kind. Depth is the scored quality by the middle of a doctoral term. Where a prompt sets a minimum number, the honest way to reach it is another consequence clause rather than another item with nothing attached to it.
Where can I find a free DNRS 6521 Week 5 sample paper?
This page shows the full post on three age-related changes and the two replies, and its margin notes trace how each change ends in a consequence for the drug.
How does aging change drug distribution in DNRS 6521 Week 5?
More body fat and less body water mean lipid-soluble drugs spread further and linger, while water-soluble drugs reach higher concentrations from the same dose.